Literature DB >> 2443131

Bombesin-like peptides elevate cytosolic calcium in small cell lung cancer cells.

T W Moody, A Murphy, S Mahmoud, G Fiskum.   

Abstract

The ability of bombesin-like peptides to elevate intracellular Ca2+ levels in small cell lung cancer cells was investigated using the fluorescent Ca2+ indicator Fura 2. Nanomolar concentrations of bombesin elevated cytosolic Ca2+ levels in the absence or presence of extracellular Ca2+. Potent bombesin receptor agonists, such as gastrin releasing peptide (GRP) or (GRP)14-27 elevated cytosolic Ca2+ levels whereas inactive compounds such as (D-Trp8)bombesin or (GRP)1-16 did not. Furthermore, the bombesin receptor antagonist (D-Arg1, D-Pro2, D-Trp7,9, Leu11) substance P (30 microM) had no effect on the Ca2+ levels by itself but antagonized the increase in Ca2+ caused by 10 nM or 100 nM bombesin. These data suggest that bombesin receptors may regulate the release of Ca2+ from intracellular organelles in small cell lung cancer cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2443131     DOI: 10.1016/s0006-291x(87)80105-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  ML-18 is a non-peptide bombesin receptor subtype-3 antagonist which inhibits lung cancer growth.

Authors:  Terry W Moody; Samuel A Mantey; Paola Moreno; Taichi Nakamura; Enza Lacivita; Marcello Leopoldo; Robert T Jensen
Journal:  Peptides       Date:  2014-12-30       Impact factor: 3.750

2.  Bombesin/gastrin-releasing peptide receptor antagonists increase the ability of histone deacetylase inhibitors to reduce lung cancer proliferation.

Authors:  Terry W Moody; Tomoo Nakagawa; Yang Kang; Sonia Jakowlew; Daniel Chan; Robert T Jensen
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 3.  Signal transduction pathways: new targets in oncology.

Authors:  R K Sweeb; J H Beijnen
Journal:  Pharm World Sci       Date:  1993-12-17

4.  Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.

Authors:  L H Wang; J F Battey; E Wada; J T Lin; S Mantey; D H Coy; R T Jensen
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

5.  Bombesin marine toxin conjugates inhibit the growth of lung cancer cells.

Authors:  Terry W Moody; Tapas Pradhan; Samuel A Mantey; Robert T Jensen; Marcin Dyba; Deborah Moody; Nadya I Tarasova; Christopher J Michejda
Journal:  Life Sci       Date:  2008-02-14       Impact factor: 5.037

6.  Effects of receptor-selective neurokinin agonists and a neurokinin antagonist on the electrical activity of spinal cord neurones in culture.

Authors:  M Wienrich; K Reuss; J Harting
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

7.  A bombesin receptor subtype-3 peptide increases nuclear oncogene expression in a MEK-1 dependent manner in human lung cancer cells.

Authors:  H C Weber; J Walters; J Leyton; M Casibang; S Purdom; R T Jensen; D H Coy; C Ellis; G Clark; T W Moody
Journal:  Eur J Pharmacol       Date:  2001-01-19       Impact factor: 4.432

Review 8.  Neuropeptide growth factors and cancer.

Authors:  P J Woll
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

9.  Identification of lung cancer gene markers through kernel maximum mean discrepancy and information entropy.

Authors:  Zhixun Zhao; Hui Peng; Xiaocai Zhang; Yi Zheng; Fang Chen; Liang Fang; Jinyan Li
Journal:  BMC Med Genomics       Date:  2019-12-20       Impact factor: 3.063

10.  Bombesin receptor-targeted liposomes for enhanced delivery to lung cancer cells.

Authors:  Mohammad J Akbar; Pâmela C Lukasewicz Ferreira; Melania Giorgetti; Leanne Stokes; Christopher J Morris
Journal:  Beilstein J Nanotechnol       Date:  2019-12-19       Impact factor: 3.649

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.